Chemotherapy of haematological malignancies. Prognostic significance.
作者信息
Klener P
出版信息
Acta Univ Carol Med Monogr. 1979;90:7-127.
PMID:400423
Abstract
摘要
相似文献
1
Chemotherapy of haematological malignancies. Prognostic significance.血液系统恶性肿瘤的化疗。预后意义。
Acta Univ Carol Med Monogr. 1979;90:7-127.
2
[Results obtained with the clinical use of adriamycin].[阿霉素临床应用所获结果]
Haematologica. 1971;56(9):343-66.
3
[Drug therapy in hemoblastosis].[血液病的药物治疗]
Folia Clin Int (Barc). 1968 Jun;18(6):365-8.
4
When to use chemotherapy for chronic hematopoietic neoplasms.慢性造血系统肿瘤何时使用化疗。
Postgrad Med. 1968 May;43(5):176-83. doi: 10.1080/00325481.1968.11693256.
5
[Experiences with intense cytostatic therapy of malignant tumors].[恶性肿瘤强化细胞抑制疗法的经验]
Arzneimittelforschung. 1968 Sep;18(9):1182-91.
6
Treatment of myeloproliferative diseases.骨髓增殖性疾病的治疗。
Ther Hung. 1966;14(4):135-6.
7
[Rubidomycine. A new antineoplastic antibiotic].[柔红霉素。一种新型抗肿瘤抗生素]
Munch Med Wochenschr. 1968 Jun 21;110(25):1539-41.
8
[The use of betamethasone in polychemotherapy of lymphoproliferative diseases].[倍他米松在淋巴增殖性疾病多药化疗中的应用]
Minerva Med. 1980 Sep 8;71(32):2293-7.
9
The effect of THF in lymphoproliferative and myeloproliferative diseases in children.四氢叶酸在儿童淋巴增殖性疾病和骨髓增殖性疾病中的作用。
Ann N Y Acad Sci. 1979;332:172-83. doi: 10.1111/j.1749-6632.1979.tb47110.x.
10
[Circulating immune complexes in patients with lymphoproliferative and myeloproliferative diseases].[淋巴增殖性疾病和骨髓增殖性疾病患者的循环免疫复合物]
Quad Sclavo Diagn. 1984 Jun;20(2):193-202.
Zotero 插件